20th Dec 2018 17:15
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. | Details of PDMR/person closely associated with them ('PCA') | ||||
a) | Name | Mr R Simard | |||
b) | Position/status | President, Pharma Supply Chain | |||
c) | Initial notification/ amendment | Initial Notification | |||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | GlaxoSmithKline plc | |||
b) | LEI | 5493000HZTVUYLO1D793 | |||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
| |||
b) | Nature of the transaction | Cash payout of £47,832.11 less applicable tax withholding in respect of 3,231.899 notional Ordinary Shares following vesting of an award made on 16 December 2013 under the GlaxoSmithKline Deferred Investment Award plan. | |||
c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
£14.8000
| 3231.899 | ||||
d) | Aggregated information | n/a (single transaction) | |||
Aggregated volume Price | |||||
e) | Date of the transaction | 2018-12-17 | |||
f) | Place of the transaction
| n/a | |||
Related Shares:
Glaxosmithkline